Editas Medicine Stock Price History
| EDIT Stock | USD 2.19 0.05 2.23% |
Below is the normalized historical share price chart for Editas Medicine extending back to February 03, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Editas Medicine stands at 2.19, as last reported on the 2nd of December, with the highest price reaching 2.27 and the lowest price hitting 2.13 during the day.
If you're considering investing in Editas Stock, it is important to understand the factors that can impact its price. Editas Medicine secures Sharpe Ratio (or Efficiency) of -0.15, which denotes the company had a -0.15% return per unit of risk over the last 3 months. Editas Medicine exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Editas Medicine's Mean Deviation of 3.13, variance of 17.32, and Standard Deviation of 4.16 to check the risk estimate we provide.
At this time, Editas Medicine's Other Stockholder Equity is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 21.3 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 239.8 M in 2024. . At this time, Editas Medicine's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 2.31 in 2024, whereas Price Earnings To Growth Ratio is likely to drop 0.15 in 2024. Editas Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of February 2016 | 200 Day MA 5.0817 | 50 Day MA 3.0714 | Beta 2.006 |
Editas |
Sharpe Ratio = -0.1542
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EDIT |
Estimated Market Risk
| 4.16 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.64 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Editas Medicine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Editas Medicine by adding Editas Medicine to a well-diversified portfolio.
Price Book 1.0528 | Enterprise Value Ebitda (1.36) | Price Sales 2.994 | Shares Float 76.2 M | Wall Street Target Price 8.1539 |
Editas Medicine Stock Price History Chart
There are several ways to analyze Editas Stock price data. The simplest method is using a basic Editas candlestick price chart, which shows Editas Medicine price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 13, 2024 | 3.95 |
| Lowest Price | December 2, 2024 | 2.19 |
Editas Medicine December 2, 2024 Stock Price Synopsis
Various analyses of Editas Medicine's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Editas Stock. It can be used to describe the percentage change in the price of Editas Medicine from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Editas Stock.| Editas Medicine Price Action Indicator | (0.04) | |
| Editas Medicine Price Daily Balance Of Power | (0.36) | |
| Editas Medicine Price Rate Of Daily Change | 0.98 | |
| Editas Medicine Accumulation Distribution | 145,988 |
Editas Medicine December 2, 2024 Stock Price Analysis
Editas Stock Price History Data
The price series of Editas Medicine for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 has a statistical range of 1.75 with a coefficient of variation of 14.04. Under current investment horizon, the daily prices are spread out with arithmetic mean of 3.23. The median price for the last 90 days is 3.27.| Open | High | Low | Close | Volume | ||
| 12/02/2024 | 2.25 | 2.27 | 2.13 | 2.19 | 2,367,090 | |
| 11/29/2024 | 2.24 | 2.28 | 2.21 | 2.24 | 1,402,887 | |
| 11/27/2024 | 2.24 | 2.28 | 2.18 | 2.20 | 1,631,103 | |
| 11/26/2024 | 2.34 | 2.34 | 2.13 | 2.21 | 3,228,280 | |
| 11/25/2024 | 2.41 | 2.53 | 2.35 | 2.38 | 5,644,332 | |
| 11/22/2024 | 2.39 | 2.54 | 2.33 | 2.44 | 2,276,879 | |
| 11/21/2024 | 2.45 | 2.47 | 2.30 | 2.37 | 2,889,553 | |
| 11/20/2024 | 2.47 | 2.48 | 2.35 | 2.41 | 2,814,305 | |
| 11/19/2024 | 2.51 | 2.56 | 2.47 | 2.48 | 2,090,349 | |
| 11/18/2024 | 2.69 | 2.69 | 2.51 | 2.52 | 2,108,493 | |
| 11/15/2024 | 2.80 | 2.80 | 2.59 | 2.66 | 2,503,185 | |
| 11/14/2024 | 2.96 | 2.98 | 2.76 | 2.77 | 1,708,348 | |
| 11/13/2024 | 3.15 | 3.20 | 2.95 | 2.96 | 1,223,615 | |
| 11/12/2024 | 3.25 | 3.25 | 3.05 | 3.07 | 1,507,372 | |
| 11/11/2024 | 3.17 | 3.38 | 3.15 | 3.30 | 2,253,334 | |
| 11/08/2024 | 3.16 | 3.24 | 3.07 | 3.12 | 1,652,788 | |
| 11/07/2024 | 3.27 | 3.30 | 3.11 | 3.17 | 2,077,651 | |
| 11/06/2024 | 3.33 | 3.40 | 3.06 | 3.28 | 4,225,856 | |
| 11/05/2024 | 2.86 | 3.17 | 2.79 | 3.12 | 2,151,616 | |
| 11/04/2024 | 2.90 | 3.08 | 2.70 | 2.88 | 3,951,521 | |
| 11/01/2024 | 2.92 | 3.03 | 2.90 | 2.91 | 1,874,601 | |
| 10/31/2024 | 3.03 | 3.03 | 2.90 | 2.90 | 1,965,525 | |
| 10/30/2024 | 3.06 | 3.15 | 3.01 | 3.02 | 1,693,611 | |
| 10/29/2024 | 3.26 | 3.36 | 3.06 | 3.11 | 2,196,596 | |
| 10/28/2024 | 3.19 | 3.32 | 3.19 | 3.26 | 1,340,994 | |
| 10/25/2024 | 3.17 | 3.36 | 3.17 | 3.18 | 1,170,332 | |
| 10/24/2024 | 3.19 | 3.22 | 3.06 | 3.18 | 1,692,522 | |
| 10/23/2024 | 3.28 | 3.31 | 3.17 | 3.21 | 2,380,890 | |
| 10/22/2024 | 3.75 | 3.75 | 3.23 | 3.29 | 3,326,508 | |
| 10/21/2024 | 3.35 | 3.80 | 3.28 | 3.76 | 4,575,813 | |
| 10/18/2024 | 3.32 | 3.41 | 3.32 | 3.36 | 859,756 | |
| 10/17/2024 | 3.46 | 3.49 | 3.25 | 3.31 | 1,238,382 | |
| 10/16/2024 | 3.38 | 3.55 | 3.36 | 3.45 | 1,378,500 | |
| 10/15/2024 | 3.24 | 3.41 | 3.17 | 3.36 | 1,194,537 | |
| 10/14/2024 | 3.19 | 3.25 | 3.10 | 3.24 | 1,540,981 | |
| 10/11/2024 | 2.94 | 3.19 | 2.92 | 3.19 | 2,265,425 | |
| 10/10/2024 | 3.09 | 3.11 | 2.91 | 2.96 | 2,588,463 | |
| 10/09/2024 | 3.17 | 3.19 | 3.10 | 3.12 | 2,627,222 | |
| 10/08/2024 | 3.20 | 3.23 | 3.13 | 3.17 | 1,516,661 | |
| 10/07/2024 | 3.34 | 3.42 | 3.18 | 3.21 | 1,530,943 | |
| 10/04/2024 | 3.30 | 3.48 | 3.25 | 3.38 | 3,074,429 | |
| 10/03/2024 | 3.20 | 3.25 | 3.15 | 3.20 | 1,915,303 | |
| 10/02/2024 | 3.22 | 3.32 | 3.18 | 3.22 | 1,784,863 | |
| 10/01/2024 | 3.44 | 3.44 | 3.22 | 3.27 | 1,770,361 | |
| 09/30/2024 | 3.48 | 3.62 | 3.39 | 3.41 | 1,546,078 | |
| 09/27/2024 | 3.54 | 3.63 | 3.43 | 3.48 | 2,060,729 | |
| 09/26/2024 | 3.46 | 3.53 | 3.41 | 3.49 | 1,693,055 | |
| 09/25/2024 | 3.51 | 3.54 | 3.37 | 3.39 | 1,634,242 | |
| 09/24/2024 | 3.70 | 3.70 | 3.50 | 3.53 | 2,243,504 | |
| 09/23/2024 | 3.73 | 3.75 | 3.60 | 3.66 | 2,167,409 | |
| 09/20/2024 | 3.89 | 3.89 | 3.67 | 3.77 | 5,770,066 | |
| 09/19/2024 | 4.01 | 4.11 | 3.90 | 3.91 | 2,498,611 | |
| 09/18/2024 | 4.01 | 4.12 | 3.86 | 3.88 | 3,101,560 | |
| 09/17/2024 | 3.91 | 4.02 | 3.81 | 3.86 | 3,126,847 | |
| 09/16/2024 | 3.96 | 3.96 | 3.76 | 3.83 | 1,544,175 | |
| 09/13/2024 | 3.78 | 3.97 | 3.78 | 3.95 | 1,291,717 | |
| 09/12/2024 | 3.79 | 3.84 | 3.64 | 3.75 | 1,123,613 | |
| 09/11/2024 | 3.73 | 3.79 | 3.63 | 3.78 | 1,191,757 | |
| 09/10/2024 | 3.54 | 3.79 | 3.45 | 3.77 | 1,841,939 | |
| 09/09/2024 | 3.64 | 3.64 | 3.48 | 3.51 | 1,941,737 | |
| 09/06/2024 | 3.49 | 3.62 | 3.40 | 3.59 | 1,966,929 |
About Editas Medicine Stock history
Editas Medicine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Editas is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Editas Medicine will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Editas Medicine stock prices may prove useful in developing a viable investing in Editas Medicine
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 76 M | 49.3 M | |
| Net Loss | -198.4 M | -188.5 M |
Editas Medicine Quarterly Net Working Capital |
|
Editas Medicine Stock Technical Analysis
Editas Medicine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Editas Medicine Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Editas Medicine's price direction in advance. Along with the technical and fundamental analysis of Editas Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Editas to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.92) | |||
| Total Risk Alpha | (1.37) | |||
| Treynor Ratio | (0.35) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Editas Stock Analysis
When running Editas Medicine's price analysis, check to measure Editas Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Editas Medicine is operating at the current time. Most of Editas Medicine's value examination focuses on studying past and present price action to predict the probability of Editas Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Editas Medicine's price. Additionally, you may evaluate how the addition of Editas Medicine to your portfolios can decrease your overall portfolio volatility.